Clinical effectiveness of recommended antibiotics in COVID19 pneumonias; assessing national referral centre guidance
E. Bellou (Athens, Greece), E. Keramida (Athens, Greece), I. Bracka (Athens, Greece), I. Karampinis (Athens, Greece), A. Paraskevas (Athens, Greece), C. Gkriniouk (Athens, Greece), D. Zorpidou (Athens, Greece), P. Demertzis (Athens, Greece), G. Hardavella (Athens, Greece)
Source: Virtual Congress 2021 – COVID - 19 treatments
Session: COVID - 19 treatments
Session type: E-poster
Number: 3679
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Bellou (Athens, Greece), E. Keramida (Athens, Greece), I. Bracka (Athens, Greece), I. Karampinis (Athens, Greece), A. Paraskevas (Athens, Greece), C. Gkriniouk (Athens, Greece), D. Zorpidou (Athens, Greece), P. Demertzis (Athens, Greece), G. Hardavella (Athens, Greece). Clinical effectiveness of recommended antibiotics in COVID19 pneumonias; assessing national referral centre guidance. 3679
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: